Interferon-Gamma Suppresses Cyclooxygenase-2 Promoter Activity by Inhibiting C-Jun and C/Ebp Beta Binding

Wu-Guo Deng,Alberto J. Montero,Kenneth K. Wu
DOI: https://doi.org/10.1161/atvbaha.107.144352
2007-01-01
Arteriosclerosis Thrombosis and Vascular Biology
Abstract:Objective - Cyclooxygenase- 2 (COX-2) and interferon gamma ( IFN gamma) are overexpressed in vascular inflammatory and atherosclerotic lesions. We postulated that IFN gamma suppresses COX-2 expression at the transcriptional level.Methods and Results - The effect of IFN gamma on COX-2 expression was evaluated in several types of human cells stimulated with phorbol 12-myristate 13-acetate ( PMA), interleukin ( IL)-1 beta, or tumor necrosis factor ( TNF) alpha. IFN gamma concentration-dependently inhibited COX-2 proteins and promoter activities induced by PMA or cytokines in human fibroblasts and monocytic and endothelial cells. PMA and cytokines stimulate binding of C-Jun, C-Fos, CCAAT/enhancer binding protein beta (C/EBP beta), or NF-kappa B to their respective regulatory elements on COX-2 promoter. IFN gamma blocked C-Jun and C/EBP beta but not C-Fos or p50 NF-kappa B binding as determined by in vitro binding assays and chromatin immunoprecipitation assay. p300 binding to COX-2 promoter was inhibited by IFN gamma in a manner comparable to C-Jun and C/EBP beta binding.Conclusions - IFN gamma suppresses proinflammatory mediator-induced COX-2 transcription by selective inhibition of C-Jun and C/EBP beta DNA binding activity and p300 recruitment in human cells. Because IFN gamma is coexpressed with COX-2 in vascular lesions, it may play a role in controlling COX-2-mediated inflammatory changes.
What problem does this paper attempt to address?